Exploring MIPLA. To explore a different substance…

Names:
LA-Me/iso · MIPLA · Lamide · N-Isopropyl-N-methyllysergamide
IUPAC name:
(8β)-N,6-Dimethyl-N-(propan-2-yl)-9,10-didehydroergoline-8-carboxamide
ID: 5327 · Formula: C20H25N3O · Molecular weight: 323.432
InChI: InChI=1S/C20H25N3O/c1-12(2)23(4)20(24)14-8-16-15-6-5-7-17-19(15)13(10-21-17)9-18(16)22(3)11-14/h5-8,10,12,14,18,21H,9,11H2,1-4H3/t14-,18-/m1/s1

Nichols, DE. Structure-activity relationships of serotonin 5-HT2A agonists. WIREs Membr. Transp. Signal, 1 Sep 2012, 1 (5), 559-579. 573 kB. http://dx.doi.org/10.1002/wmts.42

Watts, VJ; Mailman, RB; Lawler, CP; Neve, KA; Nichols, DE. LSD and structural analogs: Pharmacological evaluation at D1 dopamine receptors. Psychopharmacology, 1 Jan 1995, 118 (4), 401–409. 1.4 MB. http://dx.doi.org/10.1007/BF02245940

Huang, X; Marona-Lewicka, D; Pfaff, RC; Nichols, DE. Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives. Pharmacol. Biochem. Behav., 1 Jan 1994, 47 (3), 667–673. 650 kB. http://dx.doi.org/10.1016/0091-3057(94)90172-4

Pfaff, RC; Huang, X; Marona-Lewicka, D; Oberlender, R; Nichols, DE. Lysergamides revisited. In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1994; pp 52–73. 181 kB.

Nichols, DE. LSD and its lysergamide cousins. In Heffter Review; Nichols, DE, Ed., Heffter Research Institute, Santa Fe, NM, 2001; Vol. 2, pp 80–87. 270 kB.

Parrish, JC. Toward a molecular understanding of hallucinogen action. Ph. D. Thesis, Purdue University, West Lafayette, IN, 1 Jan 2006. 5.5 MB.

Braden, MR. Towards a biophysical understanding of hallucinogen action. Ph. D. Thesis, Purdue University, West Lafayette, IN, 1 Jan 2007. 8.4 MB.

LSD
LA-111
N-Methyllysergamide
LAE-32 · N-Ethyllysergamide
N-Propyllysergamide
Ergonovine
N-Butyllysergamide
LSB · N-Butan-2-yllysergamide
Methergine
N-Pentyllysergamide
N-Pentan-2-yllysergamide
LSP · N-Pentan-3-yllysergamide
N-Hexyllysergamide
N-Hexan-2-yllysergamide
N-Heptyllysergamide
N-Heptan-2-yllysergamide
DAM-57 · N,N-Dimethyllysergamide
N-Ethyl-N-methyllysergamide
LAMPA · LMP
5328
N-Ethyl-N-propyllysergamide
N,N-Dipropyllysergamide
DIPLA · N,N-Diisopropyllysergamide
DAL
5334
LSH
IPLA · N-Isopropyllysergamide
EIPLA · N-Ethyl-N-isopropyllysergamide
LA-CH2CF3
5083
LA-MeO
LA-Pyr · LPD-824
5336
LA-Pip
LA-Morph · LSM-775
LA-SS-Az
LA-Cispyr
LA-RR-Az
LA-RS-Az
LA-Aziridine
12-MeO-6-Me-Ergoline
5705
5707
6-Me-Ergoline
Descarboxylysergic acid
LSD
N-Butyllysergamide
LSB · N-Butan-2-yllysergamide
LAMPA · LMP
l-LSD
d-iso-LSD
l-iso-LSD
LSD
LA-111
N-Methyllysergamide
LAE-32 · N-Ethyllysergamide
N-Propyllysergamide
Ergonovine
N-Butyllysergamide
LSB · N-Butan-2-yllysergamide
Methergine
N-Pentyllysergamide
N-Pentan-2-yllysergamide
LSP · N-Pentan-3-yllysergamide
N-Hexyllysergamide
N-Hexan-2-yllysergamide
N-Heptyllysergamide
N-Heptan-2-yllysergamide
DAM-57 · N,N-Dimethyllysergamide
N-Ethyl-N-methyllysergamide
LAMPA · LMP
5328
N-Ethyl-N-propyllysergamide
N,N-Dipropyllysergamide
DIPLA · N,N-Diisopropyllysergamide
DAL
5334
LSH
IPLA · N-Isopropyllysergamide
EIPLA · N-Ethyl-N-isopropyllysergamide
LA-CH2CF3
5083
LA-MeO
LA-Pyr · LPD-824
5336
LA-Pip
LA-Morph · LSM-775
LA-SS-Az
LA-Cispyr
LA-RR-Az
LA-RS-Az
LA-Aziridine
12-MeO-6-Me-Ergoline
5705
5707
6-Me-Ergoline
Descarboxylysergic acid
LSD
N-Butyllysergamide
LSB · N-Butan-2-yllysergamide
LAMPA · LMP
l-LSD
d-iso-LSD
l-iso-LSD
22 November 2017 · Creative Commons BY-NC-SA ·